Back to results
US 12,753,245 B2Granted
Luciferase linked immunosorbent assay
AssigneeInstitut Pasteur
InventorsThierry Rose, Sophie Goyard, Laurent Lionel Reber, Yves Janin
Life of this patent
Estimating the term…
Abstract
The present invention relates to a fusion protein comprising: —a N-terminal domain which comprises an antibody which is a variable domain of a camelid heavy-chain antibody (VHH) or a single chain variable fragment (scFV) and which is directed against an immunoglobulin and —a C-terminal domain which comprises a polypeptide with a luciferase activity: —having the amino acid sequence SEQ ID NO: 1 or —having at least 80% amino acid sequence identity to the amino acid sequence SEQ ID NO: 1.
Claims24
A luciferase having at least 95% amino acid sequence identity to the amino acid sequence SEQ ID NO:
- 1 and comprising at least one amino acid substitution selected from the group consisting of:
- substitution of the tyrosine (Y) at a position corresponding to the position 18 of SEQ ID NO:
- 1 with an arginine (R),
- substitution of the leucine (L) at a position corresponding to the position 48 of SEQ ID NO:
- 1 with a lysine (K),
- substitution of the tyrosine (Y) at a position corresponding to the position 116 of SEQ ID NO:
- 1 with a phenylalanine (F),
- substitution of the tryptophan (W) at a position corresponding to the position 134 of SEQ ID NO:
- 1 with an amino acid selected from the group consisting of a threonine (T) and glutamate (E), and
- substitution of the tryptophan (W) at a position corresponding to the position 163 of SEQ ID NO:
- 1 with an amino acid selected from the group consisting of a threonine (T) and glutamate (E).
8 more elements
Dependencies are inferred from the claim text.